Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Ahmed Saadani HassaniJonathan E Kaplan

Abstract

Cotrimoxazole (CTX) prophylaxis is among the key interventions provided to HIV-infected individuals in resource-limited settings. We conducted a systematic review of the available evidence. MEDLINE, Embase, Global Health, CINAHL, SOCA, and African Index Medicus (AIM) were used to identify articles relevant to the CTX prophylaxis intervention from 1995 to 2014. Included articles addressed impact of CTX prophylaxis on the outcomes of mortality, morbidity, retention in care, quality of life, and/or prevention of ongoing HIV transmission. We rated the quality of evidence in individual articles and assessed the overall quality of the body of evidence, the expected impact, and the cost effectiveness (CE) for each outcome. Of the initial 1418 identified articles, 42 met all inclusion criteria. These included 9 randomized controlled trials, 26 observational studies, 2 systematic reviews with meta-analysis, 1 other systematic review, and 4 CE studies. The overall quality of evidence was rated as "good" and the expected impact "high" for both mortality and morbidity. The overall quality of evidence from the 4 studies addressing retention in care was rated as "poor," and the expected impact on retention was rated as "uncertain." The 4 ass...Continue Reading

References

Nov 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·B M GreenwoodR W Snow
Aug 10, 1999·Lancet·M J BoereeM E Molyneux
Aug 18, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·H P BeckC Menendez
Oct 21, 2003·AIDS·Philippe MsellatiUNKNOWN Côte d'Ivoire HIV Drug Access Initiative Socio-Behavioural Evaluation Group
Jul 28, 2005·Tropical Medicine & International Health : TM & IH·Martin J BoereeEduard E Zijlstra
Jul 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Christine WateraJonathan Mermin
Sep 15, 2006·The New England Journal of Medicine·Sue J GoldieKenneth A Freedberg
Mar 1, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Christian PitterJonathan Mermin
Jan 16, 2008·Archives of Internal Medicine·Lara R FairallRonald D Chapman
Jul 12, 2008·BMJ : British Medical Journal·Andrew J NunnUNKNOWN UNZA-UCLMS Project LUCOT Collaboration
May 1, 2010·Bulletin of the World Health Organization·Anand A DateCharlie Gilks
May 15, 2010·AIDS Care·Joep J van OosterhoutMark Manary
Nov 3, 2010·Global Health Action·Andinet Worku Alemu, Miguel San Sebastián
Jan 14, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Taiwo O Abimbola, Barbara J Marston
Jan 28, 2012·Journal of the International AIDS Society·Poh-Lian LimUNKNOWN TREAT Asia HIV Observational Database
Mar 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D CampbellJordan W Tappero
Mar 17, 2012·Bulletin of the World Health Organization·Amitabh B SutharAnnelies Van Rie
Dec 18, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elise KlementEric Caumes
Dec 24, 2013·Infectious Diseases in Obstetrics and Gynecology·Anna DowCharles van der Horst
Jan 15, 2014·PloS One·Christopher J HoffmannNeil A Martinson
Mar 15, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jonathan E KaplanMoses H Bateganya

❮ Previous
Next ❯

Citations

Mar 15, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carol L LangleyKerry Dierberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.